Masimo Corp
NASDAQ:MASI
Masimo Corp
NASDAQ:MASI
Price:
136.14 USD
0.67%
Market Closed
Updated:
Apr 27, 2024
EV/S
Enterprise Value to Sales
Enterprise Value to Sales
3.9
Current
4.8
Median
2.5
Industry
Lower
than median
Higher
than industry value
Enterprise Value to Sales (EV/S) ratio is a valuation multiple that compares the enterprise value (EV) of a company to its revenues. The EV/S multiple gives investors a quantifiable metric of how to value a company based on its sales while taking account of both the company's equity and debt.
EV/S
=3.9
Enterprise Value
/
7.9B
Revenue
2B
All Countries
| Market Cap | EV/S | ||||
|---|---|---|---|---|---|
| US |
|
Masimo Corp
NASDAQ:MASI
|
7.2B USD | 3.9 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
186.5B USD | 4.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
133.1B USD | 17.5 | |
| US |
|
Stryker Corp
NYSE:SYK
|
127.6B USD | 6.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
107.2B USD | 8.1 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106B USD | 3.8 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
66.9B USD | 4.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
59.1B EUR | 3.2 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
52B USD | 8.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
47.9B USD | 13.2 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
349.3B CNY | 9.6 |
EV/S Forward Multiples
Forward EV/S multiple is a version of the EV/S ratio that uses forecasted revenue for the EV/S calculation. 1-Year, 2-Years, and 3-Years forwards use revenue forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/S
3.7
2-Years Forward
EV/S
3.5
3-Years Forward
EV/S
3.3
You don't have any saved screeners yet
